Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Youth-onset type 2 diabetes is a heterogeneous disease with increasing prevalence in relation to increased rates of obesity in children. It has genetic, epigenetic, social, and environmental determinants. Youth-onset type 2 diabetes is alarming given a rapidly progressive course compared with the course of adult-onset disease, early-onset vascular complications, and long-term exposure to hyperglycemia and associated complications. It is often preceded by prediabetes, a disease phase where defects in β-cell function relative to insulin sensitivity emerge. Herein, we review the current understanding of the pathophysiology of prediabetes and type 2 diabetes in youth. We describe the mechanisms underlying insulin resistance, the precipitous decline of β-cell function, and the role of other hormonal abnormalities in the pathogenesis of the disease. We discuss the critical importance of social determinants of health in the predisposition and progression of these conditions and present current management strategies and the advances in therapeutic approaches. These must adapt to meet the unique needs of the individual patient and family. Significant knowledge gaps remain that need to be addressed in future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although there is some individual responsibility for maintaining a healthy weight, 133 this approach oversimplifies the interplay of genes, biology, and environmental factors influencing weight gain (reviewed in the first two papers in this Series 11,12 ).134”
From Managing early-onset type 2 diabetes in the individual and at the population level (2025) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Felitti, V. J., Anda, R. F., Nordenberg, D., Williamson, D. F., Spitz, A. M., Edwards, V., Koss, M. P., & Marks, J. S. (1998) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00017-8 · Cited by 18,943
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Inflammatory mechanisms linking obesity and metabolic disease
Saltiel, A. R., & Olefsky, J. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92035 · Cited by 2,212
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Drucker, D. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.001 · Cited by 2,170
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102
Young-Hyman, D., de Groot, M., Hill-Briggs, F., Gonzalez, J. S., Hood, K., & Peyrot, M. (2016) · Diabetes Care · doi:10.2337/dc16-2053 · Cited by 1,072
McLaughlin, K. A., Greif Green, J., Gruber, M. J., Sampson, N. A., Zaslavsky, A. M., & Kessler, R. C. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2277 · Cited by 992
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
Smith, G. I., Shankaran, M., Yoshino, M., Schweitzer, G. G., Chondronikola, M., Beals, J. W., Okunade, A. L., Patterson, B. W., Nyangau, E., Field, T., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134165 · Cited by 771
Research works printed but not linked: 66
- Kwak, 2024, Genetic architecture and biology of youth-onset type 2 diabetes, Nat Metab, 6, 226, 10.1038/s42255-023-00970-0 · DOI
- Bacha, 2024, Distinct amino acid profile characterizes youth with or at risk for type 2 diabetes, Diabetes, 73, 628, 10.2337/db23-0375 · DOI
- Bacha, 2021, Metabolic flexibility across the spectrum of glycemic regulation in youth, JCI Insight, 6, e146000
- Bacha, 2003, Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors, J Clin Endocrinol Metab, 88, 2534, 10.1210/jc.2002-021267 · DOI · Paper page
- D’Adamo, 2010, Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents, Diabetes Care, 33, 1817, 10.2337/dc10-0284 · DOI · Paper page
- Lawrence, 2011, Relationship of intramyocellular lipid to insulin sensitivity may differ with ethnicity in healthy girls and women, Obesity (Silver Spring), 19, 43, 10.1038/oby.2010.148 · DOI
- Tricò, 2018, Metabolic features of nonalcoholic fatty liver (NAFL) in obese adolescents: findings from a multiethnic cohort, Hepatology, 68, 1376, 10.1002/hep.30035 · DOI
- Castorani, 2020, Insulin resistance and type 2 diabetes in children, Ann Pediatr Endocrinol Metab, 25, 217, 10.6065/apem.2040090.045 · DOI
- Pulgaron, 2014, Obesity and type 2 diabetes in children: epidemiology and treatment, Curr Diab Rep, 14, 508, 10.1007/s11892-014-0508-y · DOI · Paper page
- Travers, 1995, Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children, J Clin Endocrinol Metab, 80, 172
- Ball, 2006, Longitudinal changes in insulin sensitivity, insulin secretion, and beta-cell function during puberty, J Pediatr, 148, 16, 10.1016/j.jpeds.2005.08.059 · DOI · Paper page
- Bacha, 2010, From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation, Diabetes Care, 33, 2225, 10.2337/dc10-0004 · DOI · Paper page
- Cali', 2008, Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents, J Clin Endocrinol Metab, 93, 1767, 10.1210/jc.2007-1722 · DOI · Paper page
- Bacha, 2012, Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study, Pediatr Diabetes, 13, 376, 10.1111/j.1399-5448.2011.00841.x · DOI · Paper page
- TODAY Study Group;, 2012, A clinical trial to maintain glycemic control in youth with type 2 diabetes, N Engl J Med, 366, 2247, 10.1056/NEJMoa1109333 · DOI · Paper page
- RISE Consortium Investigators, 2019, Effects of treatment of impaired glucose tolerance or recently diagnosed type 2 diabetes with metformin alone or in combination with insulin glargine on β-cell function: comparison of responses in youth and adults, Diabetes, 68, 1670
- RISE Consortium, 2018, Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: I. observations using the hyperglycemic clamp, Diabetes Care, 41, 1696, 10.2337/dc18-0244 · DOI · Paper page
- RISE Consortium, 2018, Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: II. Observations using the oral glucose tolerance test, Diabetes Care, 41, 1707, 10.2337/dc18-0243 · DOI · Paper page
- Utzschneider, 2020, β-Cells in youth with impaired glucose tolerance or early type 2 diabetes secrete more insulin and are more responsive than in adults, Pediatr Diabetes, 21, 1421, 10.1111/pedi.13113 · DOI
- TODAY Study Group, 2021, Postintervention effects of varying treatment arms on glycemic failure and β-cell function in the TODAY trial, Diabetes Care, 44, 75, 10.2337/dc20-0622 · DOI
- Weiss, 2011, Basal alpha-cell up-regulation in obese insulin-resistant adolescents, J Clin Endocrinol Metab, 96, 91, 10.1210/jc.2010-1275 · DOI · Paper page
- Michaliszyn, 2014, β-Cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes, Diabetes, 63, 3846, 10.2337/db13-1951 · DOI · Paper page
- Holst, 2009, The incretin system and its role in type 2 diabetes mellitus, Mol Cell Endocrinol, 297, 127, 10.1016/j.mce.2008.08.012 · DOI · Paper page
- Knop, 2007, Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?, Diabetes, 56, 1951, 10.2337/db07-0100 · DOI · Paper page
- Kim, 2008, Role of mitochondrial dysfunction in insulin resistance, Circ Res, 102, 401, 10.1161/CIRCRESAHA.107.165472 · DOI · Paper page
- Mukai, 2022, Role of reactive oxygen species in glucose metabolism disorder in diabetic pancreatic β-cells, Biomolecules, 12, 1228, 10.3390/biom12091228 · DOI
- Turer, 2012, Adiponectin: mechanistic insights and clinical implications, Diabetologia, 55, 2319, 10.1007/s00125-012-2598-x · DOI · Paper page
- Bacha, 2004, Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and β-cell function, Diabetes Care, 27, 547, 10.2337/diacare.27.2.547 · DOI · Paper page
- Butler, 2017, Social determinants of health and racial/ethnic disparities in type 2 diabetes in youth, Curr Diab Rep, 17, 60, 10.1007/s11892-017-0885-0 · DOI · Paper page
- Deschênes, 2018, Adverse childhood experiences and the risk of diabetes: examining the roles of depressive symptoms and cardiometabolic dysregulations in the Whitehall II cohort study, Diabetes Care, 41, 2120, 10.2337/dc18-0932 · DOI
- Shomaker, 2011, Longitudinal study of depressive symptoms and progression of insulin resistance in youth at risk for adult obesity, Diabetes Care, 34, 2458, 10.2337/dc11-1131 · DOI · Paper page
- Walders-Abramson, 2014, Relationships among stressful life events and physiological markers, treatment adherence, and psychosocial functioning among youth with type 2 diabetes, J Pediatr, 165, 504, 10.1016/j.jpeds.2014.05.020 · DOI
- Ievers-Landis, 2015, Longitudinal correlates of health risk behaviors in children and adolescents with type 2 diabetes, J Pediatr, 166, 1258, 10.1016/j.jpeds.2015.01.019 · DOI
- TODAY Study Group, 2013, Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial, Diabetes Care, 36, 1735, 10.2337/dc12-2420 · DOI · Paper page
- Dabelea, 2017, Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood, JAMA, 317, 825, 10.1001/jama.2017.0686 · DOI · Paper page
- Al-Saeed, 2016, An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes, Diabetes Care, 39, 823, 10.2337/dc15-0991 · DOI · Paper page
- Styne, 2017, Pediatric obesity-assessment, treatment, and prevention: an Endocrine Society Clinical practice guideline, J Clin Endocrinol Metab, 102, 709, 10.1210/jc.2016-2573 · DOI · Paper page
- Garnett, 2013, Optimal macronutrient content of the diet for adolescents with prediabetes; RESIST a randomised control trial, J Clin Endocrinol Metab, 98, 2116, 10.1210/jc.2012-4251 · DOI
- Perkison, 2018, Dietary interventions and type 2 diabetes in youth: a fresh look at the evidence, Curr Nutr Rep, 7, 227, 10.1007/s13668-018-0241-2 · DOI
- Kriska, 2018, Impact of lifestyle behavior change on glycemic control in youth with type 2 diabetes, Pediatr Diabetes, 19, 36, 10.1111/pedi.12526 · DOI
- Dorenbos, 2021, Effect of a high protein/low glycaemic index diet on insulin resistance in adolescents with overweight/obesity-a PREVIEW randomized clinical trial, Pediatr Obes, 16, e12702, 10.1111/ijpo.12702 · DOI
- Mayer-Davis, 2001, Low-fat diets for diabetes prevention, Diabetes Care, 24, 613, 10.2337/diacare.24.4.613 · DOI
- Marson, 2016, Effects of aerobic, resistance, and combined exercise training on insulin resistance markers in overweight or obese children and adolescents: a systematic review and meta-analysis, Prev Med, 93, 211, 10.1016/j.ypmed.2016.10.020 · DOI
- Herbst, 2015, Impact of regular physical activity on blood glucose control and cardiovascular risk factors in adolescents with type 2 diabetes mellitus--a multicenter study of 578 patients from 225 centres, Pediatr Diabetes, 16, 204, 10.1111/pedi.12144 · DOI
- Slaght, 2021, Physical activity and cardiometabolic health in adolescents with type 2 diabetes: a cross-sectional study, BMJ Open Diabetes Res Care, 9, e002134, 10.1136/bmjdrc-2021-002134 · DOI
- Savoye, 2014, Reversal of early abnormalities in glucose metabolism in obese youth: results of an intensive lifestyle randomized controlled trial, Diabetes Care, 37, 317, 10.2337/dc13-1571 · DOI · Paper page
- Peña, 2022, Effects of a diabetes prevention program on type 2 diabetes risk factors and quality of life among Latino youths with prediabetes: a randomized clinical trial, JAMA Netw Open, 5, e2231196, 10.1001/jamanetworkopen.2022.31196 · DOI
- Kenney, 2016, The impact of a home-based diabetes prevention and management program on high-risk American Indian youth, Diabetes Educ, 42, 585, 10.1177/0145721716658357 · DOI
- Love-Osborne, 2018, Longitudinal follow up of dysglycemia in overweight and obese pediatric patients, Pediatr Diabetes, 19, 199, 10.1111/pedi.12570 · DOI · Paper page
- Garnett, 2014, Improved insulin sensitivity and body composition, irrespective of macronutrient intake, after a 12 month intervention in adolescents with pre-diabetes; RESIST a randomised control trial, BMC Pediatr, 14, 289, 10.1186/s12887-014-0289-0 · DOI · Paper page
- Marcus, 2017, Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience, Pediatr Obes, 12, 337, 10.1111/ijpo.12148 · DOI
- Shomaker, 2016, A randomized controlled trial to prevent depression and ameliorate insulin resistance in adolescent girls at risk for type 2 diabetes, Ann Behav Med, 50, 762, 10.1007/s12160-016-9801-0 · DOI
- Glazier, 2006, A systematic review of interventions to improve diabetes care in socially disadvantaged populations, Diabetes Care, 29, 1675, 10.2337/dc05-1942 · DOI · Paper page
- Bacha, 2018, Initial presentation of type 2 diabetes in adolescents predicts durability of successful treatment with metformin monotherapy: insights from the Pediatric Diabetes Consortium T2D Registry, Horm Res Paediatr, 89, 47, 10.1159/000481687 · DOI
- Tamborlane, 2019, Liraglutide in children and adolescents with type 2 diabetes, N Engl J Med, 381, 637, 10.1056/NEJMoa1903822 · DOI · Paper page
- Tamborlane, 2022, Once-weekly exenatide in youth with type 2 diabetes, Diabetes Care, 45, 1833, 10.2337/dc21-2275 · DOI · Paper page
- Arslanian, 2022, Once-weekly dulaglutide for the treatment of youths with type 2 diabetes, N Engl J Med, 387, 433, 10.1056/NEJMoa2204601 · DOI · Paper page
- Thornberry, 2009, Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4), Best Pract Res Clin Endocrinol Metab, 23, 479, 10.1016/j.beem.2009.03.004 · DOI · Paper page
- Laffel, 2023, Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial, Lancet Diabetes Endocrinol, 11, 169, 10.1016/S2213-8587(22)00387-4 · DOI · Paper page
- Klein, 2014, Liraglutide’s safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial, Diabetes Technol Ther, 16, 679, 10.1089/dia.2013.0366 · DOI · Paper page
- Shehadeh, 2023, Dapagliflozin or saxagliptin in pediatric type 2 diabetes, NEJM Evid, 2, 10.1056/EVIDoa2300210 · DOI
- Tamborlane, 2022, Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study, Lancet Diabetes Endocrinol, 10, 341, 10.1016/S2213-8587(22)00052-3 · DOI
- Hampl, 2023, Executive summary: clinical practice guideline for the evaluation and treatment of children and adolescents with obesity, Pediatrics, 151, e2022060641, 10.1542/peds.2022-060641 · DOI
- Bensignor, 2022, Anti-obesity pharmacotherapy for treatment of pediatric type 2 diabetes: review of the literature and lessons learned from adults, Front Endocrinol (Lausanne), 13, 1043650, 10.3389/fendo.2022.1043650 · DOI
- Kelly, 2022, Phentermine/topiramate for the treatment of adolescent obesity, NEJM Evid, 1, 10.1056/evidoa2200014, 10.1056/EVIDoa2200014 · DOI · Paper page
- Miras, 2013, Mechanisms underlying weight loss after bariatric surgery, Nat Rev Gastroenterol Hepatol, 10, 575, 10.1038/nrgastro.2013.119 · DOI · Paper page
Cited by
Managing early-onset type 2 diabetes in the individual and at the population level
Misra, S., Khunti, K., Goyal, A., Gable, D., Armocida, B., Tandon, N., Sachdev, P., Wild, S. H., Hivert, M.-F., & Beran, D. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01067-0 · Cited by 47
Metadata
- Authors
- Bacha, F., Hannon, T. S., Tosur, M., Pike, J. M., Butler, A., Tommerdahl, K. L., & Zeitler, P. S.
- Affiliations
- 1USDA/ARS Children’s Nutrition Research Center, Baylor College of Medicine, Houston, TX
- 3Division of Pediatric Endocrinology and Diabetology, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN
- 5Division of Psychology, Department of Pediatrics, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX
- 6Section of Endocrinology, Department of Pediatrics, Children’s Hospital Colorado, University of Colorado Anschutz Medical Campus, Aurora, CO
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2024-09-09
- Volume
- 47
- Issue
- 12
- Pages
- 2038-2049
- ISSN
- 0149-5992
- 1935-5548
- Cited by
- 57
- References
- 33
- Language
- en
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK134982 (FB), K23-DK129821 (MT))
- Agricultural Research Service (CRIS Award 309251000-057-03S (FB))
- National Institute of Child Health and Human Development (HD105104-01 (FB))
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth. https://app.cochat.ai/papers/10.2337/dci24-0029
- The paper
- Bacha, F., Hannon, T. S., Tosur, M., Pike, J. M., Butler, A., Tommerdahl, K. L., & Zeitler, P. S. (2024). Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth. Diabetes Care. https://doi.org/10.2337/dci24-0029
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.